Analyst Ratings for Foamix Pharmaceuticals (FOMX)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/11/2019 | Barclays | Balaji Prasad | New Coverage | Overweight (N/A) |
10.00 (N/A) |
2.50 (2.99) |
19.6% | Details |
| 12/12/2018 | BofA Securities | Jason Gerberry | New Coverage | Buy (N/A) |
11.00 (N/A) |
4.00 (2.99) |
-25.25% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
